Brief: Hyphens Pharma International Says Unit Entered Into License And Supply Agreements
21/12/2022 01:40
Dec 21 (Reuters) - Hyphens Pharma International Ltd
HYPH.SI :
* UNIT ENTERED INTO EXCLUSIVE LICENSE AND SUPPLY AGREEMENTS
WITH
CASSIOPEA S.P.A.
Source text for Eikon: ID:nSN6QQYMH
Further company coverage: HYPH.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyphens Pharma International
See all newsBrief: Hyphens Pharma International Updates On Cerapro® Med Skin Barrier Cream
Brief: Hyphens Pharma International Says Unit Gets Exclusive Rights To Commercialise Metoject
Brief: Hyphens Pharma International Posts FY Net Income Of SGD 10.9 Million
Brief: Hyphens Pharma International Licenses Amenalief From Maruho For ASEAN
Brief: Hyphens Pharma International Posts Net Profit After Tax In 1Q2024 S$2.7 Million